APO RESEARCH · REPORT
Spine Biologics
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Product & engineering
Understand the product.
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Selected research
Industry Research
Spine Biologics Industry Research Report 2026
Market perspective
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Global Spine Biologics key players include Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, etc. Global top five manufacturers hold a share over 75%.
North America is the largest market, with a share over 60%, followed by Europe and Asia (Ex. China), both have a share about 30%.
Read the full market overview
In terms of product, Bone Graft is the largest segment, with a share over 55%. And in terms of application, the largest application is Posterior Lumbar Interbody Fusion, followed by Anterior Cervical Discectomy and Fusion, etc.
Report Scope
This report quantifies the global Spine Biologics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Spine Biologics Market by Company
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Spine Biologics Segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)
Spine Biologics Segment by Application
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Others
Spine Biologics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spine Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Spine Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spine Biologics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Spine Biologics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Spine Biologics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Spine Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bone Graft
- Bone Graft Substitute
- Platelet Rich Plasma (PRP)
- BMAC (Bone Marrow Aspirate Concentrate)
Applications
- Anterior Cervical Discectomy and Fusion
- Posterior Lumbar Interbody Fusion
- Others
Companies covered
- Medtronic
- Depuy Synthes
- Stryker Corporation
- Nuvasive
- Zimmer Biomet
- Orthofix International
- Globus Medical
- alphatec spine
- K2M
- Exactech
- Wright Medical Technology
- X-Spine
- Nutech
- Arthrex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Spine Biologics Market Size (2021-2032)
- 2.2.2 Global Spine Biologics Sales (2021-2032)
- 2.2.3 Global Spine Biologics Market Average Price (2021-2032)
- 2.3 Spine Biologics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Bone Graft
- 2.3.3 Bone Graft Substitute
- 2.3.4 Platelet Rich Plasma (PRP)
- 2.3.5 BMAC (Bone Marrow Aspirate Concentrate)
- 2.4 Spine Biologics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Anterior Cervical Discectomy and Fusion
- 2.4.3 Posterior Lumbar Interbody Fusion
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Spine Biologics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Spine Biologics Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Spine Biologics Revenue of Manufacturers (2021-2026)
- 3.4 Global Spine Biologics Average Price by Manufacturers (2021-2026)
- 3.5 Global Spine Biologics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Spine Biologics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Spine Biologics, Product Type & Application
- 3.8 Global Manufacturers of Spine Biologics, Established Date
- 3.9 Global Spine Biologics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Medtronic
- 4.1.1 Medtronic Company Information
- 4.1.2 Medtronic Business Overview
- 4.1.3 Medtronic Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Medtronic Spine Biologics Product Portfolio
- 4.1.5 Medtronic Recent Developments
- 4.2 Depuy Synthes
- 4.2.1 Depuy Synthes Company Information
- 4.2.2 Depuy Synthes Business Overview
- 4.2.3 Depuy Synthes Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Depuy Synthes Spine Biologics Product Portfolio
- 4.2.5 Depuy Synthes Recent Developments
- 4.3 Stryker Corporation
- 4.3.1 Stryker Corporation Company Information
- 4.3.2 Stryker Corporation Business Overview
- 4.3.3 Stryker Corporation Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Stryker Corporation Spine Biologics Product Portfolio
- 4.3.5 Stryker Corporation Recent Developments
- 4.4 Nuvasive
- 4.4.1 Nuvasive Company Information
- 4.4.2 Nuvasive Business Overview
- 4.4.3 Nuvasive Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nuvasive Spine Biologics Product Portfolio
- 4.4.5 Nuvasive Recent Developments
- 4.5 Zimmer Biomet
- 4.5.1 Zimmer Biomet Company Information
- 4.5.2 Zimmer Biomet Business Overview
- 4.5.3 Zimmer Biomet Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zimmer Biomet Spine Biologics Product Portfolio
- 4.5.5 Zimmer Biomet Recent Developments
- 4.6 Orthofix International
- 4.6.1 Orthofix International Company Information
- 4.6.2 Orthofix International Business Overview
- 4.6.3 Orthofix International Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Orthofix International Spine Biologics Product Portfolio
- 4.6.5 Orthofix International Recent Developments
- 4.7 Globus Medical
- 4.7.1 Globus Medical Company Information
- 4.7.2 Globus Medical Business Overview
- 4.7.3 Globus Medical Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Globus Medical Spine Biologics Product Portfolio
- 4.7.5 Globus Medical Recent Developments
- 4.8 alphatec spine
- 4.8.1 alphatec spine Company Information
- 4.8.2 alphatec spine Business Overview
- 4.8.3 alphatec spine Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 alphatec spine Spine Biologics Product Portfolio
- 4.8.5 alphatec spine Recent Developments
- 4.9 K2M
- 4.9.1 K2M Company Information
- 4.9.2 K2M Business Overview
- 4.9.3 K2M Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 K2M Spine Biologics Product Portfolio
- 4.9.5 K2M Recent Developments
- 4.10 Exactech
- 4.10.1 Exactech Company Information
- 4.10.2 Exactech Business Overview
- 4.10.3 Exactech Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Exactech Spine Biologics Product Portfolio
- 4.10.5 Exactech Recent Developments
- 4.11 Wright Medical Technology
- 4.11.1 Wright Medical Technology Company Information
- 4.11.2 Wright Medical Technology Business Overview
- 4.11.3 Wright Medical Technology Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Wright Medical Technology Spine Biologics Product Portfolio
- 4.11.5 Wright Medical Technology Recent Developments
- 4.12 X-Spine
- 4.12.1 X-Spine Company Information
- 4.12.2 X-Spine Business Overview
- 4.12.3 X-Spine Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 X-Spine Spine Biologics Product Portfolio
- 4.12.5 X-Spine Recent Developments
- 4.13 Nutech
- 4.13.1 Nutech Company Information
- 4.13.2 Nutech Business Overview
- 4.13.3 Nutech Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Nutech Spine Biologics Product Portfolio
- 4.13.5 Nutech Recent Developments
- 4.14 Arthrex
- 4.14.1 Arthrex Company Information
- 4.14.2 Arthrex Business Overview
- 4.14.3 Arthrex Spine Biologics Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Arthrex Spine Biologics Product Portfolio
- 4.14.5 Arthrex Recent Developments
5 Global Spine Biologics Market Scenario by Region
- 5.1 Global Spine Biologics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Spine Biologics Sales by Region: 2021-2032
- 5.2.1 Global Spine Biologics Sales by Region: 2021-2026
- 5.2.2 Global Spine Biologics Sales by Region: 2027-2032
- 5.3 Global Spine Biologics Revenue by Region: 2021-2032
- 5.3.1 Global Spine Biologics Revenue by Region: 2021-2026
- 5.3.2 Global Spine Biologics Revenue by Region: 2027-2032
- 5.4 North America Spine Biologics Market Facts & Figures by Country
- 5.4.1 North America Spine Biologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Spine Biologics Sales by Country (2021-2032)
- 5.4.3 North America Spine Biologics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Spine Biologics Market Facts & Figures by Country
- 5.5.1 Europe Spine Biologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Spine Biologics Sales by Country (2021-2032)
- 5.5.3 Europe Spine Biologics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Spine Biologics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Spine Biologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Spine Biologics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Spine Biologics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Spine Biologics Market Facts & Figures by Country
- 5.7.1 South America Spine Biologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Spine Biologics Sales by Country (2021-2032)
- 5.7.3 South America Spine Biologics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Spine Biologics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Spine Biologics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Spine Biologics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Spine Biologics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Spine Biologics Sales by Type (2021-2032)
- 6.1.1 Global Spine Biologics Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Spine Biologics Sales Market Share by Type (2021-2032)
- 6.2 Global Spine Biologics Revenue by Type (2021-2032)
- 6.2.1 Global Spine Biologics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Spine Biologics Revenue Market Share by Type (2021-2032)
- 6.3 Global Spine Biologics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Spine Biologics Sales by Application (2021-2032)
- 7.1.1 Global Spine Biologics Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Spine Biologics Sales Market Share by Application (2021-2032)
- 7.2 Global Spine Biologics Revenue by Application (2021-2032)
- 7.2.1 Global Spine Biologics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Spine Biologics Revenue Market Share by Application (2021-2032)
- 7.3 Global Spine Biologics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Spine Biologics Value Chain Analysis
- 8.1.1 Spine Biologics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Spine Biologics Production Mode & Process
- 8.2 Spine Biologics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Spine Biologics Distributors
- 8.2.3 Spine Biologics Customers
9 Global Spine Biologics Analyzing Market Dynamics
- 9.1 Spine Biologics Industry Trends
- 9.2 Spine Biologics Industry Drivers
- 9.3 Spine Biologics Industry Opportunities and Challenges
- 9.4 Spine Biologics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst